351 related articles for article (PubMed ID: 15802448)
1. Needle tract seeding after radiofrequency ablation of hepatic tumors.
Jaskolka JD; Asch MR; Kachura JR; Ho CS; Ossip M; Wong F; Sherman M; Grant DR; Greig PD; Gallinger S
J Vasc Interv Radiol; 2005 Apr; 16(4):485-91. PubMed ID: 15802448
[TBL] [Abstract][Full Text] [Related]
2. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma.
Livraghi T; Lazzaroni S; Meloni F; Solbiati L
Br J Surg; 2005 Jul; 92(7):856-8. PubMed ID: 15892154
[TBL] [Abstract][Full Text] [Related]
3. Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study.
Latteri F; Sandonato L; Di Marco V; Parisi P; Cabibbo G; Lombardo G; Galia M; Midiri M; Latteri MA; Craxì A
Dig Liver Dis; 2008 Aug; 40(8):684-9. PubMed ID: 18294940
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation for unresectable tumors of the liver.
Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation of needle tract seeding in hepatocellular carcinoma.
Espinoza S; Briggs P; Duret JS; Lapeyre M; de Baère T
J Vasc Interv Radiol; 2005 May; 16(5):743-6. PubMed ID: 15872331
[TBL] [Abstract][Full Text] [Related]
8. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
[TBL] [Abstract][Full Text] [Related]
9. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
10. Bleeding after percutaneous radiofrequency ablation: Successful treatment with transcatheter embolization.
Carrafiello G; Laganà D; Ianniello A; Craparo G; Recaldini C; Lumia D; Dionigi G; Cuffari S; Fugazzola C
Eur J Radiol; 2007 Feb; 61(2):351-5. PubMed ID: 17097255
[TBL] [Abstract][Full Text] [Related]
11. Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma.
Imamura J; Tateishi R; Shiina S; Goto E; Sato T; Ohki T; Masuzaki R; Goto T; Yoshida H; Kanai F; Hamamura K; Obi S; Yoshida H; Omata M
Am J Gastroenterol; 2008 Dec; 103(12):3057-62. PubMed ID: 19086957
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival after radiofrequency ablation of complex unresectable liver tumors.
Amersi FF; McElrath-Garza A; Ahmad A; Zogakis T; Allegra DP; Krasne R; Bilchik AJ
Arch Surg; 2006 Jun; 141(6):581-7; discussion 587-8. PubMed ID: 16785359
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
14. Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors.
Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Inoue K; Nakamura K; Inoue Y
J Vasc Interv Radiol; 2007 Mar; 18(3):399-404. PubMed ID: 17377186
[TBL] [Abstract][Full Text] [Related]
15. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
[TBL] [Abstract][Full Text] [Related]
16. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.
Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN
J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous radiofrequency ablation with a multiple-electrode switching-generator system.
Weisbrod AJ; Atwell TD; Callstrom MR; Farrell MA; Mandrekar JN; Charboneau JW
J Vasc Interv Radiol; 2007 Dec; 18(12):1528-32. PubMed ID: 18057287
[TBL] [Abstract][Full Text] [Related]
18. Major complications of ultrasound-guided percutaneous radiofrequency ablations for liver malignancies: single center experience.
Chen TM; Huang PT; Lin LF; Tung JN
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e445-50. PubMed ID: 17683478
[TBL] [Abstract][Full Text] [Related]
19. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
[TBL] [Abstract][Full Text] [Related]
20. Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system.
Glaiberman CB; Pilgram TK; Brown DB
J Vasc Interv Radiol; 2005 Oct; 16(10):1341-8. PubMed ID: 16221905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
